NCT00215540 · Interventional trial
SURFAXIN® Treatment for Prevention of Bronchopulmonary Dysplasia (BPD) in Very Low Birth Weight (VLBW) Infants.
Overall registry status Terminated
Phase 2
Conditions Bronchopulmonary Dysplasia, Premature Birth, Respiratory Distress Syndrome, Newborn
Delaware Valley sites
- Discovery Laboratories, Inc. · Warrington, PA · Bucks County
First posted
Registry updated
Added to the directory